News | May 11, 2023
Takeda pledges support to HAE patients through its ‘Sunrise patient support program’
Sunrise is built on four elements i.e., Awareness, Screening & Diagnosis, Treatment, and Maintenance Support
Sunrise is built on four elements i.e., Awareness, Screening & Diagnosis, Treatment, and Maintenance Support
Heavy bleeding after giving birth is globally a leading cause of death in new mothers
Company to manufacture drug substance for clinical supply of HaemaLogiX’s lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facility in Guangzhou, China
PPH is associated with almost 20 per cent of maternal mortality in India
First BTK inhibitor to show favourable trend in overall survival vs. standard-of-care chemoimmunotherapy in this setting
ALPHA Phase III trial showed first-in-class, oral, Factor D inhibitor as add-on to Ultomiris or Soliris improved haemoglobin levels and reduced anaemia and fatigue
Highly effective preservation solutions ensuring the safety and protection of personal care products
For the treatment of stenotic lesions of arteriovenous fistula in the haemodialysis management of chronic renal failure
Both the Ministries signed MoU for anaemia control among adolescent girls using Ayurveda interventions
The acquisition enriches AstraZeneca’s growing pipeline of cell therapies with GC012F
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)